Department of Neuroscience, Scripps Research, Jupiter, Florida 33458.
Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, Houston, Texas 77030.
J Neurosci. 2020 Oct 7;40(41):7980-7994. doi: 10.1523/JNEUROSCI.1367-20.2020. Epub 2020 Sep 4.
is a major genetic risk factor for global developmental delay, autism spectrum disorder, and epileptic encephalopathy. loss-of-function variants in this gene cause a neurodevelopmental disorder defined by cognitive impairment, social-communication disorder, and early-onset seizures. Cell biological studies in mouse and rat neurons have shown that regulates developing excitatory synapse structure and function, with loss-of-function variants driving formation of larger dendritic spines and stronger glutamatergic transmission. However, studies to date have been limited to mouse and rat neurons. Therefore, it remains unknown how loss of function impacts the development and function of human neurons. To address this, we used CRISPR/Cas9 technology to ablate protein expression in neurons derived from a commercially available induced pluripotent stem cell line (hiPSC) obtained from a human female donor. Reducing SynGAP protein expression in developing hiPSC-derived neurons enhanced dendritic morphogenesis, leading to larger neurons compared with those derived from isogenic controls. Consistent with larger dendritic fields, we also observed a greater number of morphologically defined excitatory synapses in cultures containing these neurons. Moreover, neurons with reduced SynGAP protein had stronger excitatory synapses and expressed synaptic activity earlier in development. Finally, distributed network spiking activity appeared earlier, was substantially elevated, and exhibited greater bursting behavior in null neurons. We conclude that regulates the postmitotic maturation of human neurons made from hiPSCs, which influences how activity develops within nascent neural networks. Alterations to this fundamental neurodevelopmental process may contribute to the etiology of -related disorders. is a major genetic risk factor for global developmental delay, autism spectrum disorder, and epileptic encephalopathy. While this gene is well studied in rodent neurons, its function in human neurons remains unknown. We used CRISPR/Cas9 technology to disrupt protein expression in neurons derived from an induced pluripotent stem cell line. We found that induced neurons lacking SynGAP expression exhibited accelerated dendritic morphogenesis, increased accumulation of postsynaptic markers, early expression of synapse activity, enhanced excitatory synaptic strength, and early onset of neural network activity. We conclude that regulates the postmitotic differentiation rate of developing human neurons and disrupting this process impacts the function of nascent neural networks. These altered developmental processes may contribute to the etiology of disorders.
是全球发育迟缓、自闭症谱系障碍和癫痫性脑病的主要遗传风险因素。该基因的功能丧失变异导致一种神经发育障碍,其特征为认知障碍、社交沟通障碍和早发性癫痫发作。在小鼠和大鼠神经元中的细胞生物学研究表明,调节发育中的兴奋性突触结构和功能,功能丧失变异导致更大的树突棘和更强的谷氨酸能传递。然而,迄今为止的研究仅限于小鼠和大鼠神经元。因此,尚不清楚功能丧失如何影响人类神经元的发育和功能。为了解决这个问题,我们使用 CRISPR/Cas9 技术在来自商业上可获得的诱导多能干细胞系(hiPSC)的神经元中敲除蛋白表达,该干细胞系来自一名人类女性供体。在发育中的 hiPSC 衍生神经元中降低 SynGAP 蛋白表达会增强树突形态发生,导致与来自同基因对照的神经元相比更大的神经元。与更大的树突场一致,我们还观察到在包含这些神经元的培养物中存在更多形态定义的兴奋性突触。此外,具有降低的 SynGAP 蛋白的神经元具有更强的兴奋性突触,并且在发育早期表达更早的突触活性。最后,在缺失神经元中,分布式网络尖峰活动出现得更早,幅度显著增加,并表现出更大的爆发行为。我们得出结论,调节来自 hiPSC 的人类神经元的有丝后成熟,这影响了新生神经网络内活动的发展。这种基本神经发育过程的改变可能导致相关疾病的病因。是全球发育迟缓、自闭症谱系障碍和癫痫性脑病的主要遗传风险因素。虽然该基因在啮齿动物神经元中研究得很好,但它在人类神经元中的功能仍然未知。我们使用 CRISPR/Cas9 技术在诱导多能干细胞系衍生的神经元中破坏蛋白表达。我们发现缺乏 SynGAP 表达的诱导神经元表现出加速的树突形态发生、增加的突触后标志物积累、早期表达的突触活性、增强的兴奋性突触强度以及神经网络活动的早期出现。我们得出结论,调节发育中人类神经元的有丝后分化率,破坏这个过程会影响新生神经网络的功能。这些改变的发育过程可能导致疾病的病因。